Page 3 - டைன் சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டைன் சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டைன் சிகிச்சை Today - Breaking & Trending Today

Aditi Soni: From Bringing Rare Disease Drugs to Community Service via Saheli and United India Association

INDIA New England News
Aditi Soni
BOSTON- A woman who never takes NO as an answer in life, Aditi Soni works hard to empower the women in her community. As President of the United India Association of New England (UIANE) and a Board Member of Saheli Boston, Ms. Soni has been at the forefront of many important support initiatives run by both organizations, in a year where everyone’s lives were effected by the coronavirus pandemic.
From UIANE’s “COVID-19 Relief Fund” that delivered hundreds of meals and groceries to the elderly and the front-line workers, to its virtual ‘Participate and Learn’ series to keep their community physically and mentally strong, to working with the Indian Medical Association of New England (IMANE) and the India Association of Greater Boston (IAGB) to host a community awareness webinar for the COVID-19 vaccine, Ms. Soni has been instrumental to these initiatives. ....

United States , United Kingdom , Newton Wellesley Hospital , Aditi Soni , Paulo Coelho , Malcolm Gladwell , Mark Twain , Mitch Albom , Shivalaya Temple , Alliance Management , Alliance Management At Dyne Therapeutics , Relief Fund , Cambridge Women Resource Group , Indian Medical Association Of New England , United India Association Of New England , India Association Of Greater Boston , We Care Charity , Management Institute , Asian American Commission Of Commonwealth , International Women Day On , United India Association , New England , Board Member , Saheli Boston , Indian Medical Association , India Association ,

Chutes & Ladders—After Verastem pit stop, bluebird vet Neumann lands at Kite

Editas Medicine
James Mullen takes over as CEO from Feb. 15.
Editas chairman Mullen will don the CEO mantle Feb. 15, taking over for current Editas chief
Cynthia Collins. Before jumping to the Editas team, Mullen was CEO and director of the CDMO Patheon later snapped up by Thermo Fisher and also served as the CEO of Biogen. In a brief release, Editas didn’t say why Collins was leaving. “It has been a privilege to lead Editas Medicine and this extremely talented team,” she said in a statement. “I am particularly proud of the progress to the clinic we have made with both in vivo and ex vivo gene edited medicines.” Collins joined Editas in 2019, picking up the role from ....

New York , United States , British Columbia , United Kingdom , Bryan Lake , San Francisco , Bhardwaj Desai , Cynthia Collins , Penrose Therapeutx , Daniel Lynch , Shannon Blalock , Fraiser Kansteiner , Eli Lilly , Patrick Mccall , Josh Smiley , Joel Sendek , Tim Trost , Isaac Ro , Guowei Fang , Charlie Newton , Lyell Immunopharma , Manny Duenas , Geoffrey Mcdonough , James Priour , David Enloe , Terry Coelho ,

Dyne Therapeutics Appoints Ashish Dugar, Ph.D., MBA, Senior Vice President, Global Head of Medical Affairs

Dyne Therapeutics Appoints Ashish Dugar, Ph.D., MBA, Senior Vice President, Global Head of Medical Affairs
February 08, 2021 07:30 ET
| Source:
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc.
Waltham, Massachusetts, UNITED STATES
Dr. Dugar Brings Over 20 Years of Experience in Medical Affairs, Clinical and Commercial Development, and Real-World Evidence, Including in Rare Muscle Disease
WALTHAM, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE) Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the appointment of Ashish Dugar, Ph.D., MBA, as senior vice president, global head of medical affairs. Dr. Dugar brings over 20 years of broad experience across medical affairs, clinical and commercial development, and real-world evidence (RWE) generation. ....

United States , Amy Reilly , Ashish Dugar , Joshua Brumm , Cellular Therapies Inc , National Institutes Of Health , Pennsylvania State University , University Of Michigan School Public Health , Pennsylvania State University College Of Medicine , Exchange Commission , Pfizer Inc , Sarepta Therapeutics Inc , Dyne Therapeutics Inc , Dugar Brings Over , Medical Affairs , Commercial Development , Real World Evidence , Rare Muscle , Sarepta Therapeutics , Intra Cellular Therapies , National Institutes , Michigan School , Pennsylvania State University College , Private Securities Litigation Reform Act , Dyne Therapeutics , Nasdaq Dyn ,

01.29.21 -- How To Establish An Effective CRO Partnership

01.29.21 How To Establish An Effective CRO Partnership

Continuing our Cell & Gene Series,
Business of Biotech features Dr. Bobby Gaspar, Orchard Therapeutics CEO, speaking on the challenges his company faces in the production of hematopoietic stem cells to treat neurometabolic disorders, primary immune deficiencies, and blood disorders. Listen now and subscribe so you never miss an episode.
Video
Josh Brumm, CEO of Dyne Therapeutics, discusses some of the “pros” to pitching virtually. Keith Vendola, M.D., CSO, and head of strategy at Rezolute, adds to the conversation by discussing the difficulty of making a human connection via Zoom. This is a segment of a larger executive virtual roundtable (EVR) that also included Markus Warmuth, M.D., CEO, of Monte Rosa Therapeutics, on the topic of “Pitching and Fundraising in the New Norm.” ....

Keith Vendola , Markus Warmuth , Josh Brumm , Dyne Therapeutics , Monte Rosa Therapeutics , New Norm , ஜோஷ் ப்ரும்ம , டைன் சிகிச்சை , மான்டே ரோசா சிகிச்சை , புதியது விதிமுறை ,

01.25.21 -- What's Hot In Gene Therapy

01/25/21 Life Science Leader Newsletter ....

Keith Vendola , Markus Warmuth , Josh Brumm , Dyne Therapeutics , Monte Rosa Therapeutics , Pitching And Fundraising In The New , ஜோஷ் ப்ரும்ம , டைன் சிகிச்சை , மான்டே ரோசா சிகிச்சை , சுருதி மற்றும் நிதி திரட்டல் இல் தி புதியது ,